Dengue vaccine could be ready by 2015: Sanofi

Jun 10, 2011

French drugs group Sanofi said Friday that its vaccine against dengue, a mosquito-borne infection that kills thousands of people around the world each year, could be launched in about four years.

"The vaccine could be available... around 2015," Jean Lang, head of at the group's subsidiary Sanofi-Pasteur, told reporters in Bangkok.

The launch date is dependent on regulatory approval in each country based on the results of trials.

The vaccine is the first for dengue to undergo advanced "Phase III" clinical trials -- the final stage before the results are submitted for regulatory approval.

About 4,000 children in the central Thai province of Ratchaburi, one of the worst affected areas in the country, are participating in a study that aims to establish the efficacy of the vaccine.

Dengue causes severe, in about 50 million people every year, mainly in developing countries. There are four strains, one of which is a potentially lethal type.

Dengue has reemerged in recent years as a serious public health threat in . There is currently no treatment, cure or vaccine.

Explore further: FDA proposes accelerated medical device approval plan

add to favorites email to friend print save as pdf

Related Stories

Thailand developing dengue vaccine: researcher

Feb 22, 2011

Researchers in Thailand say they have developed a prototype vaccine against dengue fever and will conduct further tests with the aim of bringing it to market within a decade.

US researchers hopeful for dengue vaccine

Feb 17, 2011

Promising advances have been made in the testing of possible vaccines to prevent the mosquito-borne dengue virus, which kills 25,000 people every year, researchers said Thursday.

Recommended for you

FDA proposes accelerated medical device approval plan

21 hours ago

(HealthDay)—The U.S. Food and Drug Administration has proposed a new program that would provide expedited access to high-risk medical devices intended for patients with serious conditions whose medical ...

Targeting drugs to reduce side effects

Apr 23, 2014

(Medical Xpress)—Consider ice cream – the base of which is frozen cream. Ingredients are then added to make different flavours. All these flavours are distinctly different but are created from the same foundation.

User comments : 0

More news stories

New breast cancer imaging method promising

The new PAMmography method for imaging breast cancer developed by the University of Twente's MIRA research institute and the Medisch Spectrum Twente hospital appears to be a promising new method that could ...

Breast cancer replicates brain development process

New research led by a scientist at the University of York reveals that a process that forms a key element in the development of the nervous system may also play a pivotal role in the spread of breast cancer.

Research proves nanobubbles are superstable

The intense research interest in surface nanobubbles arises from their potential applications in microfluidics and the scientific challenge for controlling their fundamental physical properties. One of the ...

Using antineutrinos to monitor nuclear reactors

When monitoring nuclear reactors, the International Atomic Energy Agency has to rely on input given by the operators. In the future, antineutrino detectors may provide an additional option for monitoring. ...